WATERTOWN, Mass., Dec. 19, 2023 /PRNewswire/ -- Fluent BioSciences, a leader in breakthrough single-cell analysis technology, and Element Biosciences, a pioneer in novel sequencing solutions, are ...

Fluent Biosciences is now a wholly owned subsidiary of Illumina, Inc. "The addition of Fluent BioSciences to Illumina will provide significant and new capabilities to our customers in a key growth ...

Last month, Illumina Inc (NASDAQ:ILMN) had to let go of Grail Inc. (NASDAQ:GRAL). Still, the DNA sequencing company has acquired Fluent BioSciences to expand its reach in single-cell analysis and ...

Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces early access availability of new kits and reagents for ...

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of GRAIL ...

Illumina Buys Fluent BioSciences July 09, 2024 — 04:23 pm EDT Written by RTTNews.com for RTTNews -> ...

Despite letting go of Grail last month, Illumina isn’t shying away from M&A. The DNA sequencing giant has now acquired Fluent BioSciences to expand its reach in single-cell analysis and ...

Fluent BioSciences, a cutting-edge life sciences company leading the charge in revolutionizing single-cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing ...

The PIPseq™ T100 kits enable any researcher to easily perform large, complex single-cell transcriptomic applications in a single reaction with no expensive capital equipment WATERTOWN, Mass ...